Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Mapatumumab, Cisplatin and Radiotherapy for Advanced Cervical Cancer

This study has been completed.
Sponsor:
Collaborator:
Human Genome Sciences Inc.
Information provided by (Responsible Party):
A.K.L. Reyners, University Medical Centre Groningen
ClinicalTrials.gov Identifier:
NCT01088347
First received: March 10, 2010
Last updated: April 21, 2015
Last verified: April 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2014
  Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)